Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Fuji
Harvard Business School
Cerilliant
US Department of Justice
Dow
Mallinckrodt
Chubb

Generated: July 22, 2018

DrugPatentWatch Database Preview

Bisoprolol fumarate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for bisoprolol fumarate and what is the scope of bisoprolol fumarate patent protection?

Bisoprolol fumarate
is the generic ingredient in four branded drugs marketed by Anda Repository, Aurobindo Pharma, Casi Pharms Inc, Mylan, Orit Labs Llc, Teva Pharms, Unichem Pharms (usa), Teva Womens, Actavis Elizabeth, Apothecon, Ivax Sub Teva Pharms, Sandoz, Teva, Unichem, Watson Labs Teva, and Teva Branded Pharm, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for bisoprolol fumarate. Twelve suppliers are listed for this compound.
Pharmacology for bisoprolol fumarate
Medical Subject Heading (MeSH) Categories for bisoprolol fumarate
Synonyms for bisoprolol fumarate
( inverted exclamation markA)-Bisoprolol (hemifumarate)
(.+/-.)-1-[[.alpha.-(2-Isopropoxyethoxy)-p-tolyl]oxy]-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-(p-((2-Isopropoxyethoxy)methyl)phenoxy)-3-isopropylamino-2-propanol hemifumarate
(+/-)-1-((ALPHA-(2-ISOPROPOXYETHOXY)-P-TOLYL)OXY)-3-(ISOPROPYLAMINO)-2-PROPANOL HEMIFUMARATE
(+/-)-1-[4-[[2-(1-Methylethoxy)ethoxy)methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemifumarate
(+/-)-Bisoprolol hemifumarate
(AfAE'A centa' notA inverted exclamation markAfasA'A inverted exclamation markAfAE'Adaggeratrade markAfA centA centa' notA inverted exclamation markA'A not)-Bisoprolol (hemifumarate)
(E)-but-2-enedioic acid; 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
(E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
(RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
(RS)-1-[4-[(2-ISOPROPOXYETHOXY)METHYL]PHENOXY]-3-(ISOPROPYLAMINO)PROPAN-2-OL HEMIFUMARATE SALT
[2-hydroxy-3-(4-{[2-(propan-2-yloxy)ethoxy]methyl}phenoxy)propyl](propan-2-yl)amine
1-(4-((2-isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol
1-(4-((2-isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol fumarate
1-(4-((2-Isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol hemifumarate
1-(4-((2-Isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol?hemifumarate
1-(4-[(2-Isopropoxyethoxy)methyl]phenoxy)-3-(isopropylamino)-2-propanol #
1-(4-{[2-(methylethoxy)ethoxy]methyl}phenoxy)-3-[(methylethyl)amino]propan-2-o l, (2E)but-2-enedioic acid
1-(propan-2-ylamino)-3-(4-{[2-(propan-2-yloxy)ethoxy]methyl}phenoxy)propan-2-ol
1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol
1-[4-(2-isopropoxyethoxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol
1-[4-[[2-(1-METHYLETHOXY)ETHOXY]METHYL]PHENOXY]-3-[(1-METHYLETHYL)AMINO]-2-PROPANOL HEMIFUMARATE
1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemifumarate salt
1-[ISOPROPYLAMINO]-3-[ISOPROPOXYETHOXYMETHYLPHENOXY]-2-PROPANOL
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol 2-butenedioate (salt)
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol
104344-23-2
104B232
105878-43-1
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2E)-2-butenedioate (1:1)
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2E)-2-butenedioate (1:1) (salt)
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (E)-2-butenedioate (1:1) (salt)
2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-
2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (.+/-.)-
2-PROPANOL, 1-[4-[[2-(1-METHYLETHOXY)ETHOXY]METHYL]PHENOXY]-3-[(1-METHYLETHYL)AMINO]-, (2E)-2-BUTENEDIOATE (2:1)
2C18H31NO4.C4H4O4
3-(4-{[2-(methylethoxy)ethoxy]methyl}phenoxy)-1-[(methylethyl)amino]propan-2-o l
344B232
66722-44-9
66722-45-0
722B449
AB0008008
AB00514681
AB00514681_09
AB00514681_10
AB00514681-08
AB0073023
AB07124
AB2000012
ABP000339
ABP000432
AC-18540
AC-5016
AC1L1DLQ
AC1NQXYZ
AC1OCEKX
ACN-048454
AK326211
AKOS005110983
AKOS005267174
AKOS015994663
AN-38456
API0005144
ARONIS24082
ARONIS24282
AX8117415
B3994
BB 0262613
BBL023591
BC213835
BCP9000418
BCP9000419
BCPP000331
BCPP000332
BDBM25751
BIS(1-{4-[(2-ISOPROPOXYETHOXY)METHYL]PHENOXY}-3-(ISOPROPYLAMINO)PROPAN-2-OL); FUMARIC ACID
Biso-Puren
Bisobloc
Bisocard
Bisocor
Bisomerck
BISOPROLOL
Bisoprolol - from tablet donated by Watson -
Bisoprolol (JAN/USAN/INN)
Bisoprolol (USAN/INN)
Bisoprolol [USAN:BAN:INN]
Bisoprolol [USAN:INN:BAN]
Bisoprolol for peak identification, European Pharmacopoeia (EP) Reference Standard
Bisoprolol for system suitability, European Pharmacopoeia (EP) Reference Standard
Bisoprolol fumarate (JP17/USP)
Bisoprolol Fumarate 1.0 mg/ml in Methanol (as free base)
Bisoprolol fumarate, European Pharmacopoeia (EP) Reference Standard
Bisoprolol fumarate, United States Pharmacopeia (USP) Reference Standard
Bisoprolol Fumarate/
Bisoprolol fumerate
Bisoprolol hemifumarate
Bisoprolol hemifumarate salt
Bisoprolol hemifumarate salt, >=98% (HPLC), solid
Bisoprolol monofumarate
Bisoprolol, analytical standard
bisoprolol; fumaric acid
Bisoprolol/
Bisoprololum
Bisoprololum [Latin]
BPBio1_000373
BSPBio_000339
C06852
C18H31NO4
C18H31NO4.C4H4O4
Cardicor
CAS-104344-23-2
CB0208
CCG-100883
CCG-213520
CCG-220330
CCG-222255
CHEBI:3127
CHEBI:3128
CHEMBL1200708
CHEMBL1472989
CHEMBL645
CL 297,939
CL 297939
CL-297939
Concor
Concor (TN)
Concor COR
CONCOR HEMIFUMARATE
Concor Plus Forte
Concore (TN)
Congescor
CPD000471619
CS-1770
CTK8E3176
D00634
D02342
D0K3ZR
DB00612
Detensiel
DETENSIEL HEMIFUMARATE
DSSTox_CID_25794
DSSTox_GSID_45794
DSSTox_RID_81134
DTXSID1045794
DTXSID6022682
EBD2158003
Emconcor
Emcor
EMCOR HEMIFUMARATE
EMD 33 512
EMD 33512
EMD-33-512
EMD-33512
EMD33512
Emvoncor
Euradal
EURADIAL HEMIFUMARATE
Eurtadal
Fondril
FT-0655754
Godal
GTPL7129
HMS1569A21
HMS2051I16
HMS2094O19
HMS2096A21
HMS2233F12
HMS3262P04
HMS3267A19
HSDB 8316
HY-B0076
I01-7040
I06-0412
Isoten
ISOTEN HEMIFUMARATE
K094
KB-217442
KB-308961
KM1031
KS-1033
L000133
LP00951
LP059881
LS-122509
LS-176537
Maintate
MCULE-4376025366
MFCD00792743
MFCD00865795
MLS001076669
MLS001401436
MolPort-001-759-082
MolPort-003-666-876
MolPort-005-937-320
MolPort-044-723-523
Monocor
Monocor (TN)
MONOCOR HEMIFUMARATE
NC00133
NCGC00024868-02
NCGC00024868-03
NCGC00024868-04
NCGC00024868-05
NCGC00024868-06
NCGC00024868-08
NCGC00024868-09
NCGC00094255-01
NCGC00261636-01
NSC-759181
NSC759181
OR019375
OR078870
OR196478
Pharmakon1600-01505704
Prestwick0_000330
Prestwick1_000330
Prestwick2_000330
Prestwick3_000330
Q-200728
Q-200729
RW2574
RZPZLFIUFMNCLY-WLHGVMLRSA-N
s1206
SAM001246618
SBB065120
SBB080729
SBI-0206894.P001
SCHEMBL20960
SCHEMBL41418
SCHEMBL41419
SMR000471619
Soloc
Soprol
SOPROL HEMIFUMARATE
SPBio_002260
ST51052761
STL355996
TA-4708
Tox21_111262
Tox21_111262_1
Tox21_113409
Tox21_500951
TR-022536
VHYCDWMUTMEGQY-UHFFFAOYSA-N
Zabesta
Zebeta
Zebeta (TN)
ZEBETA HEMIFUMARATE

US Patents and Regulatory Information for bisoprolol fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan BISOPROLOL FUMARATE bisoprolol fumarate TABLET;ORAL 075831-002 Dec 14, 2005 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075469-003 Sep 25, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075768-002 Sep 25, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075768-003 Sep 25, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for bisoprolol fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-002 Jul 31, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Womens ZEBETA bisoprolol fumarate TABLET;ORAL 019982-001 Jul 31, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
QuintilesIMS
Accenture
Merck
Citi
Harvard Business School
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.